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Summary. The Rho/Rac family is a group of Ras-related
proteins with demonstrated roles in the regulation of
proliferation and cytoskeletal structures in a number of
cell lineages. Despite this, the actual role of these
proteins in T-cells could not be addressed in vivo due to
the lack of adequate animal models. Recently, the use of
knockout and transgenic animals for Rac1, Rac2, and
RhoA has provided a genetic proof of the importance of
Rho/Rac protein in different aspects of T-cell signaling.
These animals have also allowed us to get better views
about the influence of these GTPases proteins on the
maturation decisions of immature lymphocytes and on
the signaling strategies these GTPases utilize to favor the
generation of coherent and robust immune responses.
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Introduction
The life of a lymphocyte is contingent on
interactions with neighboring cells requiring extensive
changes in the cytoskeleton. Positive and negative
selection occurs during the migration of thymocytes
through the thymus and their interaction with specific
stromal subpopulations. Both the type of stromal cell
making the contact with the thymocyte and the intensity
of such an interaction determine whether the T-cell will
live, die, or edit its TCR during the selection process.
After maturation, T-cells must interact with endothelial
cells and migrate across vessel walls to leave the blood
stream and reach peripheral tissues. Finally, lymphocytes
need to interact with antigen-presenting cells and target
cells to assure antigen recognition and a sustained
immune response. The dependence of all these processes
on changes in the actin cytoskeleton has led to the study
of the regulators that mediate actin dynamics. A group of
proteins which is the main suspect for the coordination
of this process is the Rho/Rac family of GTP-hydrolases.
This family consists of twelve members that can be
classified according to structural similarity in Rac, Rho,
and Cdc42 subfamilies. Studies in many cell lineages
have demonstrated that these GTPases work as
molecular switches that sense the extracellular stimuli
and translate them into changes of the cytoskeleton and
the transcriptome that, in turn, will affect the adhesion,
motility, gene expression, and cell cycle progression of
the stimulated cell (for a review, Van Aelst and D'Souza-
Schorey, 1997). The conservation of this function in T-
lymphocytes was recognized very early on, when it was
found that RhoA and Cdc42 had roles in cytotoxic
responses and T-cell polarity in cultured cell lines,
respectively (Lang et al., 1992; Stowers et al., 1995).
Since then, these proteins have been linked to other T-
cell functions, including second messenger production
(Angkachatchai and Finkel, 1999), spreading (D'Souza-
Schorey et al., 1998; Borroto et al., 2000), migration (del
Pozo et al., 1999), chemotaxis (Haddad et al., 2001), and
induction of cytokines (Angkachatchai and Finkel,
1999). Despite these observations, the study of the actual
role of Rho/Rac-dependent pathways using animal
models has been difficult because most of the animals
homozygous for null mutations in rho/rac genes are
embryonically lethal.
Until now, the most convincing genetic evidence for
the implication of Rho/Rac GTPases in T-cell signaling
derives from studies conducted with one of their
upstream regulators, the Vav protein. Vav is a
hematopoietic-specific nucleotide-releasing factor that
catalyzes GDP/GTP exchange on members of the
Rho/Rac family, leading to their activation during T-cell
stimulation (for a review, Bustelo, 2000). Confirming the
role of Rho/Rac proteins in cytoskeletal organization,
vav (-/-) T-cells were found incapable of triggering actin
polymerization upon TCR cross-linking. As a
consequence, the stimulated lymphocytes show defects
in receptor clustering and in the assembly of the immune
synapse. In immature lymphocytes, these defects cause a
defective transition of T-cell precursors from the CD44-
CD25+ (double negative, DN3) to the CD44-CD25-
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(DN4) stage as well as an impaired positive and negative
selection (Turner et al., 1997; Fischer et al., 1998). The
defective signaling of mature T-cells induces low levels
of interleukin-2 (IL2) secretion, resulting in lack of
proliferative responses after TCR cross-linking
(Tarakhovsky et al., 1995; Zhang et al., 1995; Turner et
al., 1997; Fischer et al., 1998). The analysis of the
signaling defects present in Vav-deficient cells revealed
some unexpected results. First, vav (-/-) cells cannot
induce Ca2+ during cell stimulation (Tarakhovsky et al.,
1995; Zhang et al., 1995; Turner et al., 1997; Fischer et
al., 1998). Secondly, Vav-deficient cells can activate
some expected downstream elements of the Rho/Rac
pathway (JNK, p38) but, instead, cannot fire the
activation of the Ras-dependent ERK pathway (Costello
et al., 1999). Although these signaling defects remain to
be fully explained biochemically, it was assumed
initially that they were due to the lack of activation of
some Rac protein. However, this hypothesis has not been
demonstrated experimentally up to now. Indeed, recent
experiments conducted in Jurkat cells have given an
unexpected twist to this story, since they suggest that
both the stimulation of Ca2+ currents and the activation
of IL2 gene transcription are independent on the
exchange activity of Vav (for a review, Bustelo, 2001).
Moreover, conflicting data still exist on the substrate
specificity of Vav protein, with reports indicating
specificity towards Rac proteins while others suggesting
a generalized activity towards all members of the
Rho/Rac family (Bustelo, 2000). At this point of the
story, therefore, it is not known with certainty which
parts of the phenotype of vav (-/-) animals are due to
what GTPase and which parts are GTPase-independent.
As we will discuss here, several reports by Flavell’s and
Cantrell’s groups have apparently solved this signaling
conundrum and, at the same time, established formal
genetic proof of the key role of Rac1, Rac2, and RhoA
proteins in different aspects of T-cell signaling. These
studies have also allowed us to get better views about the
influence of these GTPases on the maturation decisions
of immature lymphocytes and on the signaling strategies
these GTPases utilize to favor the generation of coherent
and robust immune responses.
Animal models for Rho and Rac proteins
Flavell’s group has reported for the first time the
phenotype of T-cells derived from animals lacking a
Rho/Rac subfamily member, the GTPase Rac2. Rac2
had been traditionally linked to hematopoietic responses,
given its hematopoietic-specific expression and its
implication in the oxidative burst of neutrophils. Rac2
mice were generated recently, confirming the important
role of this GTPase in neutrophil responses (Roberts et
al., 1999). The same knockout strain was utilized by
Flavell’s group to investigate the role of this GTPase in
T-cells (Yu et al., 2001). Unlike vav (-/-) animals, Rac2-
deficient mice show no detectable alterations in T-cell
development and positive/negative selection. However,
mature T-cells do show a very similar, although
significantly milder, phenotype to that displayed by vav
(-/-) animals. This work also shows that the milder effect
of the Rac2 deficiency is probably due to a
compensatory effect by the related Rac1 protein, since
this GTPase becomes overexpressed in several T-cell
populations of rac2 (-/-) animals. These results appear to
tilt the balance of the signaling basis of the Vav
phenotype towards the idea that it is caused by a
generalized defect in the activation of both Rac1 and
Rac2 GTPases. In addition to the implication of Rac2 in
the early responses of T-cells to antigens, Rac2 has been
previously shown to be important for the differentiation
of TH1 cells, probably by regulating the production of
IFN-γ (Li et al., 2000). Taken together, these results
indicate that Rac2 mediates both the proliferation of
primary T-cells as well as the differentiation of activated
helper cells into the TH1 lineage.
Two other studies recently done by Cantrell’s
laboratory have shed light on the role of two other
GTPases, Rac1 and RhoA, in T-cell signaling. To
approach the function of these GTPases in T-cells, they
have used transgenic mice expressing constitutively-
active forms of Rac1 (Rac1Q61L) or RhoA (RhoAG14V)
in thymocytes. The phenotypic analysis of these mice
indicates that Rac1 and RhoA have become specialized
in different aspects of T-cell biology, with Rac1 having
an active role in pre-T cell biology and RhoA in more
mature thymic populations. Rac1Q61L animals show an
enhanced transition of pre-T cells from the DN3 to the
DN4 maturation stage and an exacerbated negative
selection of double-positive (DP) cells that totally
eliminates the generation of helper and cytotoxic T-cells
(Gomez et al., 2000). When these animals were crossed
with rag1 (-/-) mice that cannot rearrange the TCR
genes, Rac1Q61L could trigger the transition of DN4 to
DP cells (Gomez et al., 2000), indicating that this
GTPase can substitute the pre-TCR to induce some
aspects of this maturational shift (see below). In contrast,
it has been shown by Cantrell’s group that RhoA has no
noticeable effect on pre-TCR signaling in the same type
of experiments (Corre et al., 2001). This result is
somewhat surprising, since previous publications by the
same group using transgenic mice expressing the C3
exoenzyme, a RhoA inhibitor, showed that this GTPase
is important for the survival of some pre-T cell
subpopulations and for DN4 cell proliferation
(Galandrini et al., 1997; Henning et al., 1997). These
contradictory results can be reconciled assuming that
RhoA is necessary, but not sufficient, to promote such
biological effects or, alternatively, that some of these
maturational defects are artifacts derived from the
inactivation of uncharacterized signaling molecules
sensitive to the action of this bacterial inhibitor. The
final elucidation of this riddle will be only answered
when the rhoA knockout becomes available. Despite the
relative "inactivity" of RhoA in DN cells, RhoAG14V has
significant effects in TCR signaling, resulting in
enhanced positive selection of DP cells and more robust
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proliferation of single positive (SP) T-cells upon anti-
CD3 stimulation (Corre et al., 2001).The signaling
mechanism by which this occurs has not been explored
in that report. One interesting experiment to carry out in
the future is to generate transgenic mice with switch
mutants of RhoAG14V that cannot engage specific
signaling pathways in order to identify the effector
molecules that are important in this process. A similar
approach has been done with Rac1 with very interesting
results (see below). Since positive selection is mainly
driven by activation of the ERK cascade (Sugawara et
al., 1998), another possible experiment is to cross
RhoAG14V animals with ERK1 knockouts to test the
dependency that RhoA has on ERK to promote positive
selection. Given the important role of the effector Rock
in proliferative signals in other cell types (Van Aelst and
D'Souza-Schorey, 1997), another alternative is to see the
effect of available Rock inhibitors in both positive
selection and T-cell proliferation using organotypic or in
vitro culture experiments, respectively. All these
experiments should give us in the future a much better
view of what is going on in these biological processes.
Role of Rho and Rac proteins in T-cell development
The availability of these mice has also made it
possible to dissect for the first time the intricacies of the
biological processes involved in T-cell differentiation.
For instance, it is known that the transition from DN4 to
DP cells involves the activation of several genetic
programs, including the stimulation of proliferation and
cell cycle progression of DN4 cells, the up-regulation of
CD4, CD5, and CD8 markers, and the downmodulation
of CD25 gene expression. Using complementation
studies with rag1 (-/-) mice, Cantrell’s group has
recently shown that Rac1Q61L signaling is sufficient for
the regulation of only some of these pathways. Thus,
Rac1Q61L is capable of inducing the expression of CD4,
CD8, and CD25 in the absence of pre-TCR. Instead,
Rac1Q61L cannot upregulate the CD5 marker or trigger
enough levels of proliferation of DN4 cells to restore the
low cellularity of rag1 (-/-) thymi back to wild type
levels (Gomez et al., 2000). Thus, these two responses
seem to require the separate stimulation, or co-
engagement, of other unrelated signaling pathways.
Role of Rho and Rac proteins in T-cell signaling:
clues about pathways and their cross-talks during
receptor activation
Cantrell’s group has also used these transgenic
strains to solve the problem of the identity of the
signaling pathway responsible for the abnormal pre-T
cell maturation found in vav (-/-) mice. To this end, they
crossed the Rac1 and RhoA transgenic animals with vav
knockout mice to perform rescue experiments. It was
found that Rac1Q61L, but not RhoAG14V, could restore the
abnormal DN3 to DN4 transition of Vav-deficient
thymocytes (Gomez et al., 2000; Corre et al., 2001). The
importance of these findings is two-fold. On one hand,
they demonstrate that the regulation of this maturational
transition is dependent on the exchange activity of Vav
and not on other unrelated pathways. On the other hand,
they give a firm genetic demonstration that Rac, but not
Rho or Cdc42 proteins, are the main targets of Vav in
this biological process. Collectively, all these results
indicate that Rac and Rho proteins promote quite
different signaling pathways and biological outcomes in
immature T-cells. Unfortunately, the lack of SP cells in
Rac1-expressing animals made it impossible to extend
the comparative analysis of Rac1 and RhoA to mature T-
cells (Gomez et al., 2000).
The study of GTPase function has indicated that the
generation of cellular responses to extracellular stimuli
requires the stimulation of multiple intracellular
pathways. The synchronization of these routes to give
rise to a coherent cell response appears to be achieved
using two regulatory strategies. On one hand, there is the
phenomenon known as signaling divergence, in which a
single GTPase can induce the activation of several
effector molecules. At the same time, the stimulation of
cells leads to processes of signaling convergence, where
the pathways that have been stimulated by different
GTPases establish synergistic interactions to yield more
robust signaling responses. For example, the activation
of Cdc42 in fibroblasts triggers a signaling cascade that
leads to the sequential activation of Rac1 and RhoA. Rac
and Ras pathways also have synergistic interactions at
the level of Rac GEFs, PAK, Raf, and MEK (for a
review, Bar-Sagi and Hall, 2000). The results obtained
with transgenic and knockout approaches have also
contributed to the understanding of how these signaling
mechanisms work in the lymphocyte. In regard to
signaling divergence, we are realizing that the GTPases
may require only a fraction of their effectors to induce
specific T-cell responses. For instance, the phenotype
induced by Rac1Q61L in the thymus can be reproduced
when these studies are done with a Rac1Q61L mutant that
cannot activate PAK, JNK, p38, or the cyclin D1
promoter (Rac1Q61L+Y40H) (Gomez et al., 2000). These
results suggest that only the pathway mediated by the
Rac1 effector POR1 (or other proteins binding to the
same region) is the important one to elicit the complex
developmental program of a pre-T cell. Indeed,
unrelated studies suggest that GTPases utilize complex
signaling strategies to make sure that only a subset of
their effectors are activated during specific phases of the
immune response. Perhaps the most interesting example
of this type of strategy is the regulation of JNK activity.
This kinase plays two opposite and antagonistic roles
during T-cell stimulation. At the beginning of the
immune response, JNK exerts an inhibitory role over the
secretion of IL2 and, therefore, plays a negative
influence on T-cell proliferation. At later time-points,
JNK activity plays positive roles in the differentiation of
helper lymphocytes to TH1 and TH2 subtypes (Dong et
al., 2000). To bypass the inhibitory action of JNK at the
initial stages of the immune response, lymphocytes
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maintain JNK at low levels and only increase its
concentration when helper T-cell differentiation has to
take place (Yang et al., 1998; Dong et al., 2000; Weiss et
al., 2000). All these results indicate that the signaling
output of a particular GTPase depends both on the
availability and concentration of the antigen and on the
"signaling history" of the T-cell where such stimulation
occurs. In regard to the possible convergence of
independent pathways during T-cell stimulation, it has
been demonstrated that the cross talk between Rac/RhoA
and Rac/Ras found in other cell types is also conserved
in T-cells. Thus, the expression of the C3 exoenzyme in
Rac1Q61L mice leads to the inhibition of all the
biological effects induced by Rac1Q61L in T-cell
differentiation. However, C3 does not abolish the effect
of Rac1 on negative selection, indicating that this
synergism is limited to specific signaling events (Corre
et al., 2001). These results give us some extra confidence
about the physiological significance of the results
obtained with the C3 exoenzyme, since RhoAG14V does
not trigger negative selection (Corre et al., 2001).
According to these results, it seems that the Rac1/RhoA
pathway is conserved both in fibroblasts and pre-T cells
but not in DP cells. What the authors of this work have
not addressed is the nature of the interconnection
between Rac1 and RhoA in those cells. In principle,
there are two possible explanations for this functional
interaction: the direct activation of RhoA by Rac1 or,
alternatively, a synergism between different signaling
elements activated by these two proteins. These
possibilities can be explored in the future biochemically
using these animals. For instance, if the first case is at
work, we must expect that Rac1Q61L-expressing cells
should have the endogenous RhoA protein in the
activated, GTP-bound state. This can be easily verified
by performing pull-down experiments with GST fusion
proteins containing the RhoA binding domain of some of
its known effectors (i.e., rhotekin). In the same
functional context, the examination of rac2-deficient T-
cells has demonstrated that the Rac and Ras pathways
are interconnected in T-cells, since these cells show
defective activation of the Ras/ERK pathway upon TCR
stimulation (Yu et al., 2001). Unfortunately, nobody has
looked so far at the basis of this signaling alteration
either in these mice or in the previously generated vav
(-/-) animals. Using reagents available in the market,
experiments can be designed to test the type of
connection between the Vav/Rac2 pathway and Ras.
Among the possible pathways to be explored, these
animals can be tested for the activation status of Ras,
PAK, Raf or MEK. The results of these experiments will
tell us whether the points of interaction between the Rac
and Ras previously found in other cell types are
conserved in the lymphocyte (Bar-Sagi and Hall, 2000).
Moreover, we can also explore whether T-cells may
utilize tricks of their own to activate this route. For
instance, Rac2-deficient cells have impaired activation
of PLC-γ proteins, as inferred from the low levels of
Ca2+ generation during T-cell stimulation (Yu et al.,
2001). This suggests that the activation of Ras in this
cell system can be accomplished via the activation of
PLC-γ, generation of DAG, and stimulation of RasGRP
(also known as CalDAGII), a DAG-dependent, Ras-
specific exchange factor that has essential roles in TCR
signaling (Dower et al., 2000).
The fact that much of the information discussed here
was discovered only after the generation of transgenic
and knockout mice highlights the importance of these
approaches to understand the complexities of T-cell
regulation. Taken the present and previous studies
together, we now know that Rho/Rac proteins have
specialized functions that depend on the maturational
stage of the T-cell and the stage of the immune response
in which their signaling occurs. Some of these functions
are related to the regulation of actin dynamics, while
others rely possibly on other routes that mediate the
activation of downstream effectors and the synergism
with independent pathways. Depending on the GTPase
involved, these signaling events influence the maturation
and selection of thymocytes, the proliferation of mature
lymphocytes to antigens, and/or their effector functions.
Arguably, the tissue-specific knockouts and knock-ins of
Rac1, RhoA, Cdc42, and other GTPases will give us a
new perspective on the involvement of each member of
this GTPase family in all aspects of T-cell biology.
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